We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+9.46%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$11.9B
AUM Growth
+$1.4B
(+13%)
Cap. Flow
+$748M
Cap. Flow
% of AUM
6.3%
Top 10 Holdings %
Top 10 Hldgs %
12.11%
Holding
747
New
202
Increased
220
Reduced
153
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$134M |
| 2 |
STMicroelectronics
STM
|
+$103M |
| 3 |
Meta Platforms (Facebook)
META
|
+$89.9M |
| 4 |
MetLife
MET
|
+$71.9M |
| 5 |
Gilead Sciences
GILD
|
+$70.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$161M |
| 2 |
Eli Lilly
LLY
|
+$153M |
| 3 |
MRSH
Marsh
MRSH
|
+$123M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$91.8M |
| 5 |
Electronic Arts
EA
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.43% |
| 2 | Technology | 17.4% |
| 3 | Industrials | 8.07% |
| 4 | Energy | 6.4% |
| 5 | Financials | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Syndax Pharmaceuticals
SNDX
$1.69B
| $36.5M | 0.31% |
1,896,032
+350,504
| +23% | +$7.24M |
|
102
Allegro MicroSystems
ALGM
$7.73B
| $36.1M | 0.3% |
1,548,132
+104,362
| +7% | +$2.62M |
|
103
HCA Healthcare
HCA
$87.2B
| $35.6M | 0.3% |
87,557
-44,491
| -34% | -$16.3M |
|
104
Voya Financial
VOYA
$9.01B
| $35.5M | 0.3% |
+448,327
| New | +$32M |
|
105
Dynatrace
DT
$12.9B
| $35.4M | 0.3% |
661,619
+146,319
| +28% | +$6.97M |
|
|
CTLT
106
DELISTED
CATALENT, INC.
CTLT
| $35.2M | 0.3% |
581,346
-7,487
| -1% | -$443K |
|
107
Booking.com
BKNG
$149B
| $35.2M | 0.3% |
+208,750
| New | +$32M |
|
108
Dyne Therapeutics
DYN
$4.7B
| $35.1M | 0.3% |
977,440
-256,468
| -21% | -$10.2M |
|
109
Ascendis Pharma A/S
ASND
$16B
| $35.1M | 0.3% |
235,018
+36,252
| +18% | +$4.9M |
|
110
Zoetis
ZTS
$32.4B
| $34.7M | 0.29% |
+177,542
| New | +$32.7M |
|
111
McDonald's
MCD
$192B
| $34.3M | 0.29% |
+112,564
| New | +$31M |
|
|
HCP
112
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $33.9M | 0.29% |
1,000,001
+320,001
| +47% | +$10.8M |
|
|
LBPH
113
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $33.5M | 0.28% |
1,004,705
+940,267
| +1,459% | +$32.4M |
|
114
Yum China
YUMC
$16.5B
| $33.3M | 0.28% |
739,146
+300,261
| +68% | +$9.99M |
|
|
X
115
DELISTED
US Steel
X
| $33.2M | 0.28% |
940,762
+80,761
| +9% | +$3.07M |
|
116
Krystal Biotech
KRYS
$10.1B
| $32.7M | 0.28% |
179,815
-112,103
| -38% | -$21.6M |
|
117
Pfizer
PFE
$143B
| $32.6M | 0.27% |
1,126,533
+55
| +0% | +$1.6K |
|
118
Intuitive Surgical
ISRG
$125B
| $32.1M | 0.27% |
65,249
-112,695
| -63% | -$52.5M |
|
|
P
119
Everpure Inc
P
$25.7B
| $32M | 0.27% |
+636,585
| New | +$36M |
|
120
Geron
GERN
$828M
| $32M | 0.27% |
7,038,313
-9,912,703
| -58% | -$45.1M |
|
121
Reinsurance Group of America
RGA
$15.5B
| $31.8M | 0.27% |
145,941
-2,075
| -1% | -$441K |
|
|
SMAR
122
DELISTED
Smartsheet Inc.
SMAR
| $31.5M | 0.27% |
+569,828
| New | +$27.6M |
|
123
Hewlett Packard
HPE
$63.4B
| $31.4M | 0.26% |
+1,535,830
| New | +$29.3M |
|
124
Madrigal Pharmaceuticals
MDGL
$10.8B
| $31.2M | 0.26% |
147,090
+8,781
| +6% | +$2.25M |
|
|
RNAM
125
DELISTED
Avidity Biosciences
RNAM
| $31.1M | 0.26% |
678,154
+32,496
| +5% | +$1.41M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q3 2024 Portfolio in Review
As of Q3 2024, Woodline Partners held 747 positions worth $11.9B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Woodline Partners deployed $748M of net new capital in Q3 2024, opening 202 new positions and adding to 220 existing holdings. Its largest new stake was ASML: 149,876 shares worth $125M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 42% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Eli Lilly, an estimated $153M trimmed.
- Woodline Partners's largest Q3 2024 buy was ASML: 149,876 shares worth $125M.
- Woodline Partners added most to STMicroelectronics in Q3 2024, an estimated $103M increase.
- Woodline Partners's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $153M.
- Woodline Partners fully exited TE Connectivity in Q3 2024, selling an estimated $161M.
- Woodline Partners's ten largest holdings make up 12% of its $11.9B portfolio in Q3 2024.
- Woodline Partners opened 202 new positions and closed 161 in Q3 2024.
- Woodline Partners's portfolio value rose 13% quarter-over-quarter to $11.9B.
Based on Woodline Partners's 13F filing for Q3 2024, filed 14 Nov 2024.